immunotherapy treatment may cause latent infections of Mycobacterium tuberculosis to flare up in cancer patients
Tuberculosis Can Emerge After Cancer Immunotherapy
At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.
Tuberculosis Can Emerge After Cancer Immunotherapy
Tuberculosis Can Emerge After Cancer Immunotherapy

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

At least a handful of patients have developed active TB after receiving cancer treatment designed to boost the immune system’s antitumor response.

checkpoint inhibitor
How Cancer Circumvents the Immune System
How Cancer Circumvents the Immune System
The Scientist Creative Services Team in collaboration with Bio-Techne | Dec 15, 2021
Dario Vignali and Peter Westcott will explore the importance of understanding immune-cancer mechanistic interactions for developing therapeutic approaches.
800x560 istock image
Training Immune Cells to Be Cancer Killers
Aparna Nathan | Nov 12, 2021
A career-altering experience as a cancer patient motivated one researcher to design more potent immunotherapies.
Checking Checkpoints for Treating Cancer
The Scientist Creative Services Team | Mar 31, 2021
Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.
lab tools cancer therapy
Contending with Resistance in Cancer Immunotherapy
Marissa Fessenden | Apr 1, 2019
Researchers describe ways to study how cancer cells evade therapies that harness the immune system.
car t cell infographic april 2019 the scientist solid tumor liquid cancer
Infographic: CAR-T Cells in Solid Versus Liquid Cancers
Kerry Grens | Apr 1, 2019
Tumor accessibility, heterogeneity, and microenvironment vary between the two classes of malignancies.
More Cancer Mutations, Better Immunotherapy Outcomes
Catherine Offord | Jan 15, 2019
Immune checkpoint inhibitors are generally most effective against tumors with more genetic mutations, according to a new study, although the relationship isn’t true for all cancers.
Fecal Transplant Heals Colitis Caused by Immunotherapy
Anna Azvolinsky | Nov 12, 2018
A case study of two patients with advanced cancer shows it might be possible to avoid a common and severe side effect of immunotherapy treatment.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
James Allison and Tasuku Honjo Win Nobel Prize
Ashley Yeager and Kerry Grens | Oct 1, 2018
The immunologists, honored with the 2018 award in Physiology or Medicine, pioneered immunotherapy, which harnesses the body’s immune system to fight cancer.
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Immunotherapy More Effective in Men: Study
Kerry Grens | May 18, 2018
Women with metastatic cancer who were treated with a checkpoint inhibitor had a smaller benefit than did men.